IP Library Granted Patent US 11,072,818
Granted Patent B2
US 11,072,818 · App. 16/380,846 · Granted Jul 27, 2021

Selective oxidation of 5-methylcytosine by TET-family proteins

Inventors: Anjana Rao (La Jolla, CA); Mamta Tahiliani (New York, NY); Kian Peng Koh (Jamaica Plain, MA); Suneet Agarwal (Belmont, MA); Aravind Iyer (Bethesda, MD)
Assignees: The Children's Medical Center Corporation; The United States of America, As Represented by the Secretary, Department of Health and Human Services
C12Q1/6827C12Q1/26C12Q1/6806C12Q1/6869G01N33/5308C12N2501/70C12N2501/71C12Q2521/531C12Q2522/10C12Q2537/164C12Q2600/154
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,072,818
App. No.
16/380,846
Granted
Jul 27, 2021
Kind
B2
Abstract

The present invention provides for novel methods for regulating and detecting the cytosine methylation status of DNA. The invention is based upon identification of a novel and surprising catalytic activity for the family of TET proteins, namely TET1, TET2, TET3, and CXXC4. The novel activity is related to the enzymes being capable of converting the cytosine nucleotide 5-methylcytosine into 5-hydroxymethylcytosine by hydroxylation.

Claims (9)

1. A method comprising contacting with, or delivering to a nucleic acid sequence, an enzyme or fragment thereof that oxidizes at least one methylated DNA base, in an amount effective to convert 5-methylcytosine to 5-hydroxymethylcytosine.

2. The method of claim 1 , wherein the enzyme or fragment thereof comprises a purified and isolated dioxygenase.

3. The method of claim 2 , wherein the purified and isolated dioxygenase comprises a catalytically active TET family enzyme, a functional TET family derivative, a TET catalytically active fragment thereof, or any combination thereof.

4. The method of claim 1 , wherein the contacting with or the delivering to converts a 5-methylcytosine residue in the nucleic acid sequence to a modified base.

5. The method of claim 4 , wherein the modified base is formed by more than one oxidation reaction.

6. The method of claim 4 , wherein the modified base comprises a 5-hydroxymethylcytosine residue.

7. The method of claim 1 , wherein the method comprises contacting the nucleic acid sequence with the enzyme or fragment thereof.

8. The method of claim 1 , wherein the method comprises delivering the enzyme or fragment thereof to the nucleic acid sequence.

9. The method of claim 1 , wherein the nucleic acid sequence is from a somatic cell.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2020
From: RAO, ANJANA; TAHILIANI, MAMTA; KOH, KIAN PENG
To: IMMUNE DISEASE INSTITUTE, INC.
Reel/Frame 053266/0148 →
MERGER Recorded Jul 21, 2020
From: IMMUNE DISEASE INSTITUTE, INC.
To: THE CHILDREN'S HOSPITAL CORPORATION
Reel/Frame 053266/0161 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2020
From: THE CHILDREN'S HOSPITAL CORPORATION
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 053266/0180 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2020
From: AGARWAL, SUNEET
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 053266/0187 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2020
From: IYER, ARAVIND
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 053266/0191 →
Continuity (9)
Continuation 15440815 · Feb 23, 2017
Continuation 15341344 · Nov 2, 2016
Continuation 15193796 · Jun 27, 2016
Continuation 13795739 · Mar 12, 2013
Continuation 13120861
Provisional Application 61100503 · Sep 26, 2008
Provisional Application 61100995 · Sep 29, 2008
Provisional Application 61121844 · Dec 11, 2008
Related Publication 20190233885A1 · Aug 1, 2019
Cited By (12)
US 12,228,574 US 12,247,905 US 12,291,742 US 12,331,346 US 12,338,489 US 12,372,528 US 12,410,480 US 12,454,724 US 12,467,082 US 12,503,728 US 12,630,866 US 12,682,984